127 related articles for article (PubMed ID: 147797)
1. [Dosage effect of the cytoplasmic superoxide dismutase (SOD-1) gene in the erythrocytes of Down's syndrome patients].
Tamarkina AD; Annenkov GA; Filippov IK; Lamchingiĭn T
Genetika; 1977; 13(5):929-32. PubMed ID: 147797
[TBL] [Abstract][Full Text] [Related]
2. Increased superoxide dismutase and Down's syndrome.
Turrens JF
Med Hypotheses; 2001 Jun; 56(6):617-9. PubMed ID: 11399108
[TBL] [Abstract][Full Text] [Related]
3. Transgenic mice overexpressing the human Cu/Zn-SOD gene: ultrastructural studies of a premature thymic involution model of Down's syndrome (trisomy 21).
Nabarra B; Casanova M; Paris D; Nicole A; Toyama K; Sinet PM; Ceballos I; London J
Lab Invest; 1996 Mar; 74(3):617-26. PubMed ID: 8600312
[TBL] [Abstract][Full Text] [Related]
4. Down syndrome clinical symptoms are manifested in transfected cells and transgenic mice overexpressing the human Cu/Zn-superoxide dismutase gene.
Groner Y; Elroy-Stein O; Avraham KB; Yarom R; Schickler M; Knobler H; Rotman G
J Physiol (Paris); 1990; 84(1):53-77. PubMed ID: 1972759
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of superoxide dismutase and glutathione peroxidase enzymes and their cofactors in Egyptian children with Down's syndrome.
Meguid NA; Kholoussi NM; Afifi HH
Biol Trace Elem Res; 2001 Jul; 81(1):21-8. PubMed ID: 11508329
[TBL] [Abstract][Full Text] [Related]
6. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.
Annerén G; Edman B
APMIS Suppl; 1993; 40():71-9. PubMed ID: 8311993
[TBL] [Abstract][Full Text] [Related]
7. [Significance of the type of chromosome aberrations and biochemical disorders for diagnosis of Down's syndrome and the phenotype of partial trisomy 21].
Mikiel-Kostyra K; Czerski P; Bartosz G; Sito A; Leyka W
Pediatr Pol; 1980 Jan; 55(1):23-32. PubMed ID: 6445053
[No Abstract] [Full Text] [Related]
8. A boy with Down's syndrome having recombinant chromosome 21 but no SOD-1 excess.
Miyazaki K; Yamanaka T; Ogasawara N
Clin Genet; 1987 Dec; 32(6):383-7. PubMed ID: 2963715
[TBL] [Abstract][Full Text] [Related]
9. Superoxide dismutase and glutathione peroxidase abnormalities in erythrocytes and lymphoid cells in Down syndrome.
Frischer H; Chu LK; Ahmad T; Justice P; Smith GF
Prog Clin Biol Res; 1981; 55():269-89. PubMed ID: 6457303
[TBL] [Abstract][Full Text] [Related]
10. [Effect of gene dose in human cells].
Annenkov GA
Tsitol Genet; 1978; 12(4):362-70. PubMed ID: 151956
[TBL] [Abstract][Full Text] [Related]
11. Red cell superoxide dismutase, glutathione peroxidase and catalase in Down syndrome patients with and without manifestations of Alzheimer disease.
Percy ME; Dalton AJ; Markovic VD; McLachlan DR; Hummel JT; Rusk AC; Andrews DF
Am J Med Genet; 1990 Apr; 35(4):459-67. PubMed ID: 2139757
[TBL] [Abstract][Full Text] [Related]
12. On the etiopathogenesis and therapy of Down syndrome.
Antila E; Westermarck T
Int J Dev Biol; 1989 Mar; 33(1):183-8. PubMed ID: 2534992
[TBL] [Abstract][Full Text] [Related]
13. Cell damage by excess CuZnSOD and Down's syndrome.
Groner Y; Elroy-Stein O; Avraham KB; Schickler M; Knobler H; Minc-Golomb D; Bar-Peled O; Yarom R; Rotshenker S
Biomed Pharmacother; 1994; 48(5-6):231-40. PubMed ID: 7999984
[TBL] [Abstract][Full Text] [Related]
14. [Changes in the mole fraction ratio of lactate dehydrogenase subunits in the lymphocytes of Down's syndrome patients].
Tamarkina AD; Filippov IK; Annenkov GA; Beniashvili GKh
Genetika; 1978 Feb; 14(2):354-8. PubMed ID: 150994
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of oxygen derivatives in down's syndrome.
Sinet PM
Ann N Y Acad Sci; 1982; 396():83-94. PubMed ID: 6217779
[No Abstract] [Full Text] [Related]
16. Moderate Down's syndrome in three siblings having partial trisomy 21q22.2 to qter and therefore no SOD-1 excess.
Habedank M; Rodewald A
Hum Genet; 1982; 60(1):74-7. PubMed ID: 6210617
[No Abstract] [Full Text] [Related]
17. Twofold CuZnSOD activity suggesting homozygous submicroscopic duplication of chromosome 21 in the orangutan.
de Grouchy J; Nicole A; Cochet C; Créau-Goldberg N; Sinet PM
Ann Genet; 1988; 31(2):73-4. PubMed ID: 2969695
[TBL] [Abstract][Full Text] [Related]
18. Radiation sensitivity of Down's syndrome fibroblasts might be due to overexpressed Cu/Zn-superoxide dismutase (EC 1.15.1.1).
Schwaiger H; Weirich HG; Brunner P; Rass C; Hirsch-Kauffmann M; Groner Y; Schweiger M
Eur J Cell Biol; 1989 Feb; 48(1):79-87. PubMed ID: 2526018
[TBL] [Abstract][Full Text] [Related]
19. Types of enzymatic overdosing in trisomy 21: erythrocytic superoxide dismutase-AJ and phosphoglucomutase.
Prişcu R; Sichitiu S
Humangenetik; 1975 Aug; 29(1):79-83. PubMed ID: 126209
[TBL] [Abstract][Full Text] [Related]
20. Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome.
Ceballos-Picot I; Nicole A; Briand P; Grimber G; Delacourte A; Defossez A; Javoy-Agid F; Lafon M; Blouin JL; Sinet PM
Brain Res; 1991 Jun; 552(2):198-214. PubMed ID: 1717112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
